169 filings
424B3
TLSI
TriSalus Life Sciences Inc
15 May 24
Prospectus supplement
4:33pm
424B3
TLSI
TriSalus Life Sciences Inc
15 May 24
Prospectus supplement
4:30pm
10-Q
2024 Q1
TLSI
TriSalus Life Sciences Inc
Quarterly report
15 May 24
9:07am
8-K
TLSI
TriSalus Life Sciences Inc
15 May 24
TriSalus Reports Q1 2024 Financial Results and Business Update
8:30am
424B3
TLSI
TriSalus Life Sciences Inc
7 May 24
Prospectus supplement
4:08pm
424B3
o7947ri mqkwnf
7 May 24
Prospectus supplement
4:04pm
8-K
slqpjwfg
7 May 24
Departure of Directors or Certain Officers
4:01pm
424B3
omkqv001zb186gni0o
30 Apr 24
Prospectus supplement
5:02pm
424B3
0ysjhgko xlgwg
30 Apr 24
Prospectus supplement
5:01pm
8-K
558qbim6sykgh35u id
30 Apr 24
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNavĀ® Infusion System Growth Initiatives
5:00pm
EFFECT
9n3olms
25 Apr 24
Notice of effectiveness
12:15am
EFFECT
tnb6v
25 Apr 24
Notice of effectiveness
12:15am
POS AM
4xt2de87dii hnyxz
16 Apr 24
Prospectus update (post-effective amendment)
6:36pm
POS AM
0frjk 7ej83v
16 Apr 24
Prospectus update (post-effective amendment)
6:31pm
8-K
rab1ysl
15 Apr 24
Changes in Registrant's Certifying Accountant
5:43pm
S-8
qjot3w9cc0rb9tn6a
11 Apr 24
Registration of securities for employees
5:14pm
NT 10-K
aihwh595
2 Apr 24
Notice of late annual filing
6:07am
8-K
1or ugu8ov
1 Apr 24
TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
8:05am
8-K
bp6uhva zl
11 Mar 24
Results of Operations and Financial Condition
9:25pm